Ads
related to: metastatic renal cell carcinoma- Dosing Details
Get Information About
Dosing for WELIREG.
- Efficacy for WELIREG
Find Clinical Trial Results
for WELIREG.
- Ask Merck
Connect With a Merck Associate Now
or Schedule a Call.
- Safety Information
View Safety and Adverse
Reaction Information for WELIREG.
- Read Guidelines
See Clinical Practice Guidelines
for WELIREG.
- Explore Resources
Find Professional Resources
for WELIREG.
- Dosing Details
Search results
Drug targeting clear cell renal cell carcinoma shows promising approach
Newswise· 4 days agoApril 23, 2024 – In a groundbreaking phase one clinical trial led by UT Southwestern Medical Center,...
Allogene secures $15 million grant for cancer trial By Investing.com
Investing.com· 17 hours agoThe funding is earmarked to support the Phase 1 TRAVERSE trial, which is evaluating the safety and...
Junshi Biosciences Announces NDA Acceptance in Hong Kong for Toripalimab
Morningstar· 2 days agoThe NDA is supported by results from JUPITER...
Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
Zacks· 2 days agoFree Report) reported adjusted earnings of $2.07 per share for first-quarter 2024, beating the Zacks Consensus Estimate of $1.94. Earnings rose 48% year over year on a reported basis and 54% ...
Merck (MRK) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 1 day agoOutside the U.S., KEYTRUDA growth was driven by continued uptake in earlier-stage cancers, including high-risk, early stage, triple-negative breast...
Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting
FOX 4 Kansas City· 2 days agoFirst-in-class PD-1/IL-2 bispecific antibody fusion protein IBI363 in patients with advanced...
Mirae Asset Global Investments Co. Ltd. Trims Stock Position in Iovance Biotherapeutics, Inc....
ETF DAILY NEWS· 4 days agoMirae Asset Global Investments Co. Ltd. trimmed its stake in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) by 3.4% during the fourth quarter, according to its most recent 13F filing ...
Merck highlights progress on HIV, hypertension, cervical cancer drugs
WFMZ Eastern Pennsylvania and Western New Jersey· 2 days agoMerck got off to an excellent start in the first quarter of 2024. Wall Street met the news with...
Cancer drug trial provides lessons for future
Medical Xpress· 2 days agoA cancer drug was found to be ineffective in preventing recurrence of kidney cancer in patients who recently underwent tumor removal surgery, according to a clinical trial published in the Journal ...
How Should You Play Merck (MRK) Stock Ahead of Q1 Earnings?
Zacks via Yahoo Finance· 4 days agoInvestor focus is likely to be on the sales of Merck's (MRK) blockbuster oncology medicine,...
Ads
related to: metastatic renal cell carcinoma
